ABEV · Ambev S.A.

Ambev S.A.’s Q1 2026 results reflect modest top-line stability and improved profitability despite a slight decline in net sales year-over-year. Net sales decreased by R$32.9 million (0.1%) to R$22.46 billion, while gross profit rose marginally to R$11.58 billion — suggesting favorable cost management or product mix shifts. Operating income increased 4.9% to R$5.99 billion, supported by lower distribution, commercial, and administrative expenses collectively, and a small positive contribution from other operating income. Net financial results improved significantly: net financial expenses fell to R$1.06 billion from R$856 million in Q1 2025, primarily due to reclassification of finance income and expense into 'Other net financial results' starting Q4 2025 — though the absolute change reflects lower net interest costs and reduced losses on derivative instruments. Income tax expense remained nearly flat at R$1.046 billion, contributing to a 2.1% increase in net income. Basic EPS rose to R$0.2414, confirming efficient capital allocation. The balance sheet remains robust, with total equity increasing by over R$2.2 billion quarter-on-quarter, driven by retained earnings and accounting adjustments under IAS 29 (hyperinflation), partially offset by carrying value adjustments. No forward guidance is disclosed in the filing, and no material events such as acquisitions, executive changes, or financing activities are reported — making this a pure interim earnings update under IAS 34. Investors should note the continued strength in operating cash flow generation (R$3.16 billion), which exceeded Q1 2025 by 162%, signaling solid underlying liquidity despite working capital outflows reflected in receivables and payables movements.